Alerts will be sent to your verified email
Verify EmailEVOQ
EVOQ Remedies
|
JFL Life Sciences
|
Deccan Health Care
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
22.13 % | 12.26 % | 0.79 % |
5yr average Equity Multiplier
|
53.05 | 2.68 | 1.17 |
5yr Average Asset Turnover Ratio
|
0.81 | 0.93 | 0.47 |
5yr Avg Net Profit Margin
|
6.55 % | 5.75 % | 1.37 % |
Price to Book
|
0.0 | 1.06 | 0.42 |
P/E
|
118.56 | 10.08 | 43.25 |
5yr Avg Cash Conversion Cycle
|
764.12 Days | 138.58 Days | 218.27 Days |
Inventory Days
|
54.66 Days | 96.42 Days | 372.92 Days |
Days Receivable
|
853.76 Days | 135.23 Days | 54.52 Days |
Days Payable
|
175.72 Days | 103.44 Days | 94.94 Days |
5yr Average Interest Coverage Ratio
|
2684.0 | 4.03 | 12.96 |
5yr Avg ROCE
|
29.72 % | 17.72 % | 2.08 % |
5yr Avg Operating Profit Margin
|
-8.09 % | 10.31 % | 7.39 % |
5 yr average Debt to Equity
|
0.24 | 0.9 | 0.02 |
5yr CAGR Net Profit
|
n/a | 50.43 % | 24.36 % |
5yr Average Return on Assets
|
3.61 % | 5.01 % | 0.68 % |
Shareholdings
|
|||
Promoter Holding
|
11.21 % | 67.47 % | 18.42 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-62.32 % | 0.0 | -16.47 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
EVOQ Remedies
|
JFL Life Sciences
|
Deccan Health Care
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|